Synthesis and in-silico studies of 4-(5-(2-(4-(5-aryl-1,2,4-thiadiazol-3-yl)phenyl)-1H-imidazol-4-yl)-1,3,4-thiadiazol-2-yl)pyridines

[Display omitted] 4-(5-(2-(4-(5-aryl-1,2,4-thiadiazol-3-yl)phenyl)-1H-imidazol-4-yl)-1,3,4-thiadiazol-2-yl) pyridines were synthesized from benzothioic O-acid and (E)-N'-hydroxy-4-(4-(5-(pyridin-4-yl)-1,3,4-thiadiazol-2-yl)-1H-imidazol-2-yl) benzamidine. New compounds synthesized were character...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Results in Chemistry 2024-01, Vol.7, p.101303, Article 101303
Hauptverfasser: Kethireddy, Shashikala, Eppakayala, Laxminarayana, Banu Syeda, Asra
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] 4-(5-(2-(4-(5-aryl-1,2,4-thiadiazol-3-yl)phenyl)-1H-imidazol-4-yl)-1,3,4-thiadiazol-2-yl) pyridines were synthesized from benzothioic O-acid and (E)-N'-hydroxy-4-(4-(5-(pyridin-4-yl)-1,3,4-thiadiazol-2-yl)-1H-imidazol-2-yl) benzamidine. New compounds synthesized were characterized by IR, 1H NMR, 13C NMR, and mass spectral analysis. The synthesized compounds were also performed for in-silico studies, particularly in relation to their activity as inhibitors of the Epidermal Growth Factor Receptor (EGFR). This approach provides a comprehensive understanding of the molecular behavior of compound and their potential as agents for inhibiting EGFR, which is of significant interest in drug discovery and development.
ISSN:2211-7156
2211-7156
DOI:10.1016/j.rechem.2023.101303